Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty
Clinical trial NCT06398275 · UNKNOWN
Trial details
- NCT number
- NCT06398275
- Sponsor
- University Hospital of Split
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-06
- Primary completion
- 2024-09-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.